中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
4期
513-514
,共2页
无创,正压,通气%肺心病%脑钠肽
無創,正壓,通氣%肺心病%腦鈉肽
무창,정압,통기%폐심병%뇌납태
Noninvasive,positive pressure,ventilation%Pulmonary heart disease%BNP
目的 探讨无创正压通气对肺心病患者脑钠肽(BNP)水平的影响.方法 选择104例肺心病患者,随机分为两组,对照组(常规治疗)和研究组(无创通气治疗),各52例.检测两组患者治疗前后的BNP水平,然后进行比较.结果 治疗后两组血浆BNP水平均明显降低,且研究组血浆BNP水平为(197.8±39.6)ng/L,更低于对照组的(320.9±43.0) ng/L(t =3.22,P＜0.05).结论 无创正压通气治疗可以有效降低肺心病患者的BNP水平.
目的 探討無創正壓通氣對肺心病患者腦鈉肽(BNP)水平的影響.方法 選擇104例肺心病患者,隨機分為兩組,對照組(常規治療)和研究組(無創通氣治療),各52例.檢測兩組患者治療前後的BNP水平,然後進行比較.結果 治療後兩組血漿BNP水平均明顯降低,且研究組血漿BNP水平為(197.8±39.6)ng/L,更低于對照組的(320.9±43.0) ng/L(t =3.22,P＜0.05).結論 無創正壓通氣治療可以有效降低肺心病患者的BNP水平.
목적 탐토무창정압통기대폐심병환자뇌납태(BNP)수평적영향.방법 선택104례폐심병환자,수궤분위량조,대조조(상규치료)화연구조(무창통기치료),각52례.검측량조환자치료전후적BNP수평,연후진행비교.결과 치료후량조혈장BNP수평균명현강저,차연구조혈장BNP수평위(197.8±39.6)ng/L,경저우대조조적(320.9±43.0) ng/L(t =3.22,P＜0.05).결론 무창정압통기치료가이유효강저폐심병환자적BNP수평.
Objective To explore influence of noninvasive positive pressure ventilation treatment on the brain natriuretic peptide(BNP) level of patients with pulmonary heart disease.Methods 104 patients with pulmonary heart disease were randomly divided into two groups,control group ( conventional therapy) and study groups ( noninvasive ventilation),each group 52 cases.The BNP level of the two groups before and after treatment were detected and compared.Results After treatment,the BNP level in the two groups were all decreased,and the BNP level of the study group was( 197.8 ± 39.6) ng/L,which was significantly lower than that of the control group[ (320.9 ± 43.0 ) ng/L ]( t =3.22,P ＜ 0.05).Conclusion Noninvasive positive pressure ventilation treatment could effectively reduce BNP level in patients with pulmonary heart disease.
